Erasca (ERAS) is down -9.9%, or -$2.13 to $19.36.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ERAS:
- Erasca sinks after Revolution Medicines alleges patent infringement
- Erasca Highlights ERAS-0015 Phase 1 Data Update
- Erasca price target raised to $30 from $20 at Stifel
- Erasca Tightens Timeline for ERAS-0015 Phase 1 Data
- ERAS: Promising RAS-Mutant Oncology Pipeline and China Partnership Support Buy Rating